The Latest Advances in Peptide Receptor Radionuclide Therapy for Gastroenteropancreatic Neuroendocrine Tumors

J Nucl Med. 2023 Jan 5;jnumed.122.264422. doi: 10.2967/jnumed.122.264422. Online ahead of print.
No abstract available

Keywords: Neuroendocrine; Radionuclide Therapy; neuroendocrine tumors; precision medicine; somatostatin receptor; targeted radionuclide therapy.